Mood disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD) are rampant in today’s world. They affect people from all walks of life, no matter their background or age. According to the World Health Organization, 300 million people around the world have depression, including 16.2 million adults in the United States. Nearly 50% of all people diagnosed with depression are also diagnosed with an anxiety disorder. The reality is we are either watching our loved ones suffer or are experiencing the debilitating effects ourselves.

An innovative new treatment option, Ketamine is an FDA-approved anesthetic that has been found to provide rapid relief from depression and anxiety when infused at a low dose. Research indicates that Ketamine stimulates the regrowth of synapses within the brain, essentially rewiring the parts of the brain that may be causing distress. Some researchers maintain a 75% success rate when treating those suffering from depression or anxiety with Ketamine Treatments.